Study Stopped
lack of funding
Feasibility Study: Comparison of Performance Status With Objective Physical Activity Monitors
OS09328 Feasibility Study: Comparison of Performance Status With Objective Physical Activity Monitors
1 other identifier
observational
6
1 country
1
Brief Summary
The purpose of this research is to examine the relationship between performance status rating and the actual amount of physical activity a subject does when it is measured by an activity monitor.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jan 2010
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2010
CompletedFirst Submitted
Initial submission to the registry
February 3, 2010
CompletedFirst Posted
Study publicly available on registry
February 5, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2011
CompletedFebruary 14, 2012
February 1, 2012
1.7 years
February 3, 2010
February 10, 2012
Conditions
Outcome Measures
Primary Outcomes (1)
To determine the feasibility of examining physical activity (through objective measurement devices) and performance status in a 14-day study of lung cancer patients.
14 days
Secondary Outcomes (1)
To determine the number of days of monitoring necessary to reliably estimate energy expenditure (steps/day, and % of time spent sedentary) in lung cancer patients undergoing chemotherapy.
14 days
Study Arms (1)
Activity monitoring
Interventions
monitoring of physical activity for 14 days using physical activity monitoring devices along with activity diary
Eligibility Criteria
Non-small cell lung cancer patients receiving chemotherapy.
You may qualify if:
- Worst Daily Pain rating of \< 4/10
- ECOG Performance Status of 0, 1, or 2
- Prior malignancy is allowed as long as it is inactive or well-controlled without current anti-tumor therapy required
You may not qualify if:
- Known brain metastasis
- Use of assistive devices (cane, crutch)
- No concurrent radiotherapy: all radiotherapy must be completed 4 weeks prior to enrollment in this study
- Patients receiving only targeted therapy are not eligible(e.g.erlotinib)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Wisconsin Carbone Cancer Center
Madison, Wisconsin, 53792, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Toby Campbell, MD
UW Madison
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 3, 2010
First Posted
February 5, 2010
Study Start
January 1, 2010
Primary Completion
September 1, 2011
Study Completion
September 1, 2011
Last Updated
February 14, 2012
Record last verified: 2012-02